| 标题 |
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Medicinal Chemistry 作者:James Cregg; Kristof Pota; Aidan C.A. Tomlinson; Jason K. Yano; Abby Marquez; et al 出版日期:2025-02-24 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)